Novo Nordisk
NVO
#32
Rank
$244.30 B
Marketcap
$107.75
Share price
3.56%
Change (1 day)
33.30%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Market capitalization of Novo Nordisk (NVO)

Market cap: $244.30 Billion

As of May 2022 Novo Nordisk has a market cap of $244.30 Billion. This makes Novo Nordisk the world's 32th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Novo Nordisk from 2001 to 2022

Year Market cap Change
2022$244.30 B-4.22%
2021$255.07 B56.42%
2020$163.07 B17.22%
2019$139.12 B24.43%
2018$111.80 B-14.74%
2017$131.12 B39.24%
2016$94.17 B-38.17%
2015$152.30 B35.23%
2014$112.62 B11.3%
2013$101.18 B11.24%
2012$90.96 B36.37%
2011$66.70 B-1.24%
2010$67.54 B66.85%
2009$40.48 B24.25%
2008$32.58 B-22.36%
2007$41.96 B58.17%
2006$26.53 B45.63%
2005$18.21 B1.1%
2004$18.02 B27.41%
2003$14.14 B40.56%
2002$10.06 B-27.62%
2001$13.90 B

End of Day market cap according to different sources

On May 20th, 2022 the market cap of Novo Nordisk was reported to be:

$247.84 Billion
by Yahoo Finance
$247.84 Billion
by CompaniesMarketCap
$244.30 Billion
by Nasdaq
$190.99 Billion
by Iex Cloud
$183.54 Billion
by Reuters

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$294.40 B 20.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$283.95 B 16.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$135.85 B-44.39%๐Ÿ‡ซ๐Ÿ‡ท France
$162.21 B-33.60%๐Ÿ‡บ๐Ÿ‡ธ USA